Sept 21 (Reuters) - Selvita SA SLV1.WA :
* SAID ON MONDAY THAT IT HAS RECEIVED 3.3 MILLION ZLOTY
SUBSIDY
FROM POLAND'S NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT FOR
COMPANY'S PROJECT
* THE PROJECT IS IMPLEMENTED WITHIN THE PROGRAM "TECHNOLOGY
PLATFORM FOR NEW GENERATIONS OF DRUGS AGAINST DISEASES CAUSED BY
CORONAVIRUSES, IN PARTICULAR SARS-COV-2"
* PROJECT'S NET VALUE IS AT 6.3 MILLION ZLOTYS
* THE AIM OF THE PROJECT IS TO INTRODUCE TECHNOLOGY, WHICH
WILL
ENABLE TO ACCELERATE THE IDENTIFICATION OF INHIBITORS OF KEY
PROTEASES INVOLVED IN THE CORONAVIRUS REPLICATION, INCLUDING
THAT OF SARS-COV-2, BY MEANS OF HIGH THROUGHPUT SCREENING OF A
FOCUSED LIBRARY CONTAINING INNOVATIVE COMPOUNDS WITH POTENTIAL
ANTIVIRAL PROPERTIES
Source text for Eikon: urn:newsml:reuters.com:*:nEM13QcBqa
Further company coverage: SLV1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))